ProVen VCT plc (PVN) has disclosed the admission of further Ordinary Shares to trading on the London Stock Exchange Main Market across two separate tranches in September and October 2026, following allotments made under a joint offer for subscription with ProVen Growth and Income VCT plc. The shares were issued pursuant to an offer launched on 17 November 2025, with additional shares also issued to existing shareholders in connection with commission payments due to their brokers. The announcement, published on 10 November 2026, was made in accordance with The Public Offers and Admissions to Trading Regulations 2024. Investors in the venture capital trust sector may be watching the total share count, which has now exceeded 300 million following both admissions.

Key Points

  • ProVen VCT plc (PVN) is a venture capital trust listed on the London Stock Exchange Main Market
  • Two tranches of new Ordinary Shares of 10p each were admitted to trading: 1,148,536 shares on 14 September 2026 and 1,480,586 shares on 8 October 2026
  • Total shares in issue reached 298,575,634 following the September admission and 300,056,220 following the October admission
  • Investors should monitor further allotment announcements under the ongoing joint offer for subscription with ProVen Growth and Income VCT plc

ProVen VCT Issues 1,148,536 New Shares Admitted on 14 September 2026

The first tranche covered in the announcement relates to 1,148,536 new Ordinary Shares of 10p each, allotted on 11 September 2026 and admitted to trading on the London Stock Exchange Main Market on 14 September 2026. Following this admission, the total number of Ordinary Shares in issue stood at 298,575,634. These shares carry ISIN GB00B8GH9P84 and are described as fully fungible with the company's existing Ordinary Shares. The admission was disclosed in accordance with Public Offers and Admissions to Trading Regulations 2024, specifically under PRM 1.6.4R, covering all admissions up to and including 14 September 2026.

Second Tranche of 1,480,586 Shares Admitted to Trading on 8 October 2026

The second tranche comprised 1,480,586 new Ordinary Shares of 10p each, allotted on 7 October 2026 and admitted to trading on 8 October 2026. Following this second admission, the total number of Ordinary Shares in issue rose to 300,056,220, crossing the 300 million mark. As with the first tranche, the new shares are fully fungible with existing Ordinary Shares and carry the same ISIN: GB00B8GH9P84. This notification covers all admissions up to and including 8 October 2026, the company stated, with Beringea LLP acting as Company Secretary and listed as the contact for enquiries.

Joint Offer for Subscription with ProVen Growth and Income VCT plc Underpins Both Allotments

Both share allotments stem from a joint offer for subscription launched on 17 November 2025 in conjunction with ProVen Growth and Income VCT plc, a structure common among VCT managers seeking to raise capital across related funds simultaneously. A supplementary prospectus was published on 22 June 2026. VCTs raise funds to invest in qualifying smaller UK companies, offering investors potential tax reliefs under UK legislation. The ongoing nature of the offer means further allotments and admissions remain possible, which investors in the VCT sector may continue to monitor as the fundraising period progresses.